Arcus Biosciences Q1 EPS $(1.02) Misses $(0.93) Estimate, Sales $17.000M Miss $29.484M Estimate
Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(1.02) per share which missed the analyst consensus estimate of $(0.93) by 9.68 percent. This is a 10.53 percent increase over losses of $(1.14) per share from
